<DOC>
	<DOCNO>NCT01631903</DOCNO>
	<brief_summary>The purpose study determine safety , pharmacokinetics efficacy four dos vaginally administer Proellex premenopausal woman uterine fibroid confirm ultrasound .</brief_summary>
	<brief_title>Extension Study ZPV-200</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Healthy adult female 18 47 year age uterine fibroid confirm ultrasound . Normal , abnormal nonclinically significant , transvaginal ultrasound . History menstrual event occur regular cycle . Agreement attempt become pregnant . Agreement limit alcohol consumption 2 drink per week avoid alcohol consumption within 48 hour visit . Ability complete daily subject diary study procedure compliance protocol . Agrees use condom provide method birth control ( hormonal method , contraceptive sponge , spermicide cervical cap ) course study . Has negative pregnancy test Screening Baseline visit . An exception pregnancy test requirement grant subject provide verification surgical sterilization . A Body Mass Index ( BMI ) 18 39 inclusive . Is available treatment followup visit . Subject able insert vaginal suppository . Subject willing exclusively use sanitary napkin ( tampon ) study duration . Subject postmenopausal woman , define either ; six ( 6 ) month ( immediately prior screen visit ) without menstrual period , prior hysterectomy and/or oophorectomy . Subject pregnant lactating attempt expect become pregnant 7 month study period . Women abnormally high liver enzymes liver disease . ( ALT AST exceed 1.5x ULN AND total bilirubin exceed 1.5xULN screening confirm repeat ) . Received investigational drug 30 day prior screen study . Women history PCOS . Concurrent use testosterone , progestin , androgen , estrogen , anabolic steroid , DHEA hormonal product least 2 week prior screen study . Use oral contraceptive precede 30 day . Use DepoProveraÂ® precede 6 month . Has IUD place . Women currently use narcotic . Women currently take cimetidine spironolactone . Clinically significant abnormal finding screen examination condition , opinion investigator , would interfere participant 's ability comply study instruction endanger participant take part study . Participation study ZP204 .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>47 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>